The unified call for affordable diabetes technology masks a deeper regulatory battle. Who truly benefits from this 'access' push?
The KU/Children's Mercy theranostics center is more than a building; it's a strategic play to dominate advanced nuclear medicine, leaving competitors flat-footed.
Is everyone taking too much magnesium? We analyze the supplement hype, the real science, and the industry agenda behind the mineral craze.
One in three people carries Toxoplasma gondii. Forget the 'kill switch'; the real story behind this common parasite is far more sinister.
The push to integrate nutrition science into public policy hides a darker truth: it's a regulatory Trojan horse benefiting corporate interests over genuine public health.
The imminent human trial for cellular reprogramming isn't just about aging; it's about a radical shift in economic power. This is the true story of longevity tech.
Madrigal's massive siRNA licensing deal signals a dangerous consolidation in the MASH drug race. The real winner isn't the patient.
The narrative of African self-sufficiency in health funding is a Trojan horse. Unpacking the real power shift and the hidden costs of 'efficiency' in global health.
Dr. Dennis Slamon's honor in precision medicine masks the crushing reality of high drug costs and access inequality in modern healthcare.
Forget pharma hype. The real fight in modern healthcare isn't drugs; it's the looming shortage of skilled professionals, and university programs are the front lines.
When health insurance costs more than your mortgage, it signals a catastrophic failure in American economic priorities.
The push for Massachusetts to 'lead the fight for facts' masks a deeper battle over regulatory capture and intellectual dominance in American science.